Trial intelligence / Profile preview

Human Mesenchymal Stem Cell Conditioned Medium for Neurological Disorders

jRCT1051260127Recruiting

Sponsor
Heiwa Clinic
Start
Jul 2024
Countries
1
01

Overview

Open-label, single-arm trial in neurological diseases, hemiplegia, amyotrophic lateral sclerosis (ALS) and 2 more, sponsored by Heiwa Clinic. Primary endpoints: Neurological symptom and history assessment, Neurological function scores and 1 more. Started Jul 2024; status: recruiting.

02

Conditions

neurological diseaseshemiplegiaamyotrophic lateral sclerosis (ALS)Parkinson's disease (PD)multiple sclerosis (MS)

Beyond the preview

Go deeper on jRCT1051260127.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051260127.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call